Cercle
San Francisco, US · Founded 2020 · 32 employees on LinkedIn · 3 known investors
Cercle builds a platform that ingests and transforms healthcare data at scale into insights, with a focus on fertility and reproductive care. It serves healthcare and fertility businesses seeking to operate more efficiently and deliver more personalized care.
Also known as Cercle AI
Founders & leadership
Cercle was founded in 2020 by Andreas Melder, Dr. Irene Cuevas, and Liya Sharif Lancia.
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeedSep 2024 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026Cercle operates an AI-enabled data platform that consolidates fragmented clinical information and makes it usable for providers, clinicians and life science teams. The company frames the problem it addresses as the roughly 97% of healthcare data that is inaccessible to providers and unusable by research teams, and positions its product as a way to convert messy, multimodal inputs into AI-ready, anonymized datasets. Input types the platform handles include genomic data, medication lists, physician notes, medical records, prescriptions, case report forms, imaging and visual inputs, and discharge summaries.
The product is presented as the "Cercle Intelligence Stack," comprising an ingestion engine that anonymizes and harmonizes multimodal clinical data into a unified source of truth with built-in traceability, a biomedical graph, and an intelligence layer. On top of this foundation, Cercle offers tools for cohort discovery, natural-language exploration of patient journeys through custom AI agents, personalized care planning, and application of population-scale patterns to individual patient guidance. Outputs are described as traceable and refined over time via clinician feedback loops. The company's public news items and audience messaging center on women's health, fertility care and precision medicine.
Business model
Cercle sells access to its data and intelligence platform to healthcare organizations and life science teams, with prospective customers directed to book a demo and existing users accessing the product through a login.
Traction
The website reports 54,568 unique cohorts defined on the platform. The company launched out of stealth in November 2023 with global partners and announced a $6M seed round in September 2024.
Latest developments
In September 2024 Cercle announced a $6M seed fundraise directed at advancing women's healthcare. Earlier, in November 2023, the company emerged from stealth with global partners, with coverage describing an AI data platform backed by Sheryl Sandberg aimed at personalizing fertility care.
▸Full profile — market position, technology, go-to-market
Market position
Cercle positions itself around unlocking the large share of healthcare data that is unstructured and unused, with a stated emphasis on women's health, fertility and precision medicine for women.
Cercle emphasizes built-in traceability from ingestion through model output, anonymization and harmonization of multimodal clinical inputs, a modular foundation intended to support applications across the healthcare lifecycle, and clinician feedback loops that refine AI performance.
Technology
The platform is built around an ingestion engine that anonymizes and harmonizes multimodal clinical data — including genomic data, clinical notes, records, prescriptions, case report forms, imaging and discharge summaries — into a structured, AI-ready source of truth with traceability. A biomedical graph and an intelligence layer sit above ingestion, and custom AI agents allow natural-language querying across millions of patient journeys while returning traceable outputs subject to clinician feedback loops.
Go-to-market
Direct enterprise engagement through demo requests and an inbound contact form on the company website, supported by press coverage of its stealth launch and funding.
Two stated audiences: healthcare providers and clinicians, who use the platform to educate patients, support decisions and inform clinical pathways with real-world data; and life science teams and researchers, who use it to uncover hidden cohorts, design trials and identify new development opportunities.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 3
launches, deals, and filingsCompany news listing states Cercle secured a $6M seed fundraise to advance women's healthcare.
$6M source ↗
Company news listing references coverage of the genomics data startup launching out of stealth with global partners to drive precision medicine for women.
Company news listing references coverage of the launch of Cercle's AI data platform, described as Sheryl Sandberg-backed, to personalize fertility care.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 1
primary sources listed
- Cerclecercle.ai · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Cercle do?
- Cercle is an AI-enabled healthcare data platform that harmonizes fragmented clinical data into insight for providers and life science teams.
- Who founded Cercle?
- Cercle was founded by Andreas Melder, Dr. Irene Cuevas, Liya Sharif Lancia in 2020.
- Who are Cercle's investors?
- Cercle's investors include FemHealth Ventures, Outsiders, Rogue Womens Fund.
- Where is Cercle headquartered?
- Cercle is headquartered in San Francisco, US.